Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Novel Campylobacter concisus lipooligosaccharide is a determinant of inflammatory potential and virulence.

Brunner K, John CM, Phillips NJ, Alber DG, Gemmell MR, Hansen R, Nielsen HL, Hold GL, Bajaj-Elliott M, Jarvis GA.

J Lipid Res. 2018 Oct;59(10):1893-1905. doi: 10.1194/jlr.M085860. Epub 2018 Jul 26.

PMID:
30049709
2.

Treatment of human challenge and MDR strains of Neisseria gonorrhoeae with LpxC inhibitors.

John CM, Feng D, Jarvis GA.

J Antimicrob Chemother. 2018 Aug 1;73(8):2064-2071. doi: 10.1093/jac/dky151.

PMID:
29726994
3.

Innate immune response to lipooligosaccharide: pivotal regulator of the pathobiology of invasive Neisseria meningitidis infections.

John CM, Phillips NJ, Stein DC, Jarvis GA.

Pathog Dis. 2017 Apr 1;75(3). doi: 10.1093/femspd/ftx030. Review.

PMID:
28423169
4.

Structure of a lipid A phosphoethanolamine transferase suggests how conformational changes govern substrate binding.

Anandan A, Evans GL, Condic-Jurkic K, O'Mara ML, John CM, Phillips NJ, Jarvis GA, Wills SS, Stubbs KA, Moraes I, Kahler CM, Vrielink A.

Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2218-2223. doi: 10.1073/pnas.1612927114. Epub 2017 Feb 13.

5.

Analysis of Bacterial Lipooligosaccharides by MALDI-TOF MS with Traveling Wave Ion Mobility.

Phillips NJ, John CM, Jarvis GA.

J Am Soc Mass Spectrom. 2016 Jul;27(7):1263-76. doi: 10.1007/s13361-016-1383-3. Epub 2016 Apr 7.

PMID:
27056565
6.

Arginine- and Polyamine-Induced Lactic Acid Resistance in Neisseria gonorrhoeae.

Gong Z, Tang MM, Wu X, Phillips N, Galkowski D, Jarvis GA, Fan H.

PLoS One. 2016 Jan 25;11(1):e0147637. doi: 10.1371/journal.pone.0147637. eCollection 2016.

7.

Lipooligosaccharide Structures of Invasive and Carrier Isolates of Neisseria meningitidis Are Correlated with Pathogenicity and Carriage.

John CM, Phillips NJ, Din R, Liu M, Rosenqvist E, Høiby EA, Stein DC, Jarvis GA.

J Biol Chem. 2016 Feb 12;291(7):3224-38. doi: 10.1074/jbc.M115.666214. Epub 2015 Dec 11.

8.

Induction of endotoxin tolerance by pathogenic Neisseria is correlated with the inflammatory potential of lipooligosaccharides and regulated by microRNA-146a.

Liu M, John CM, Jarvis GA.

J Immunol. 2014 Feb 15;192(4):1768-77. doi: 10.4049/jimmunol.1301648. Epub 2014 Jan 17.

9.

Campylobacter jejuni lipooligosaccharide sialylation, phosphorylation, and amide/ester linkage modifications fine-tune human Toll-like receptor 4 activation.

Stephenson HN, John CM, Naz N, Gundogdu O, Dorrell N, Wren BW, Jarvis GA, Bajaj-Elliott M.

J Biol Chem. 2013 Jul 5;288(27):19661-72. doi: 10.1074/jbc.M113.468298. Epub 2013 Apr 29.

10.

Post-injury conditioning with lipopolysaccharide or lipooligosaccharide reduces inflammation in the brain.

Bingham D, John CM, Levin J, Panter SS, Jarvis GA.

J Neuroimmunol. 2013 Mar 15;256(1-2):28-37. doi: 10.1016/j.jneuroim.2012.12.009. Epub 2013 Jan 17.

PMID:
23333234
11.

Lack of lipid A pyrophosphorylation and functional lptA reduces inflammation by Neisseria commensals.

John CM, Liu M, Phillips NJ, Yang Z, Funk CR, Zimmerman LI, Griffiss JM, Stein DC, Jarvis GA.

Infect Immun. 2012 Nov;80(11):4014-26. doi: 10.1128/IAI.00506-12. Epub 2012 Sep 4.

12.

The association between body mass index and severe biliary infections: a multivariate analysis.

Stewart L, Griffiss JM, Jarvis GA, Way LW.

Am J Surg. 2012 Nov;204(5):574-9. doi: 10.1016/j.amjsurg.2012.07.002. Epub 2012 Aug 11.

PMID:
22892201
13.

Secretory leukocyte protease inhibitor binds to Neisseria gonorrhoeae outer membrane opacity protein and is bactericidal.

Cooper MD, Roberts MH, Barauskas OL, Jarvis GA.

Am J Reprod Immunol. 2012 Aug;68(2):116-27. doi: 10.1111/j.1600-0897.2012.01149.x. Epub 2012 Apr 26.

14.
15.

Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-β-dependent mechanisms.

Liu Y, Islam EA, Jarvis GA, Gray-Owen SD, Russell MW.

Mucosal Immunol. 2012 May;5(3):320-31. doi: 10.1038/mi.2012.12. Epub 2012 Feb 22.

16.

Human lipooligosaccharide IGG that prevents endemic meningococcal disease recognizes an internal lacto-N-neotetraose structure.

Cheng H, Yang Z, Estabrook MM, John CM, Jarvis GA, McLaughlin S, Griffiss JM.

J Biol Chem. 2011 Dec 23;286(51):43622-33. doi: 10.1074/jbc.M111.291583. Epub 2011 Oct 25.

17.

Post-injury treatment with lipopolysaccharide or lipooligosaccharide protects rat neuronal and glial cell cultures.

Bingham D, John CM, Panter SS, Jarvis GA.

Brain Res Bull. 2011 Jul 15;85(6):403-9. doi: 10.1016/j.brainresbull.2011.04.007. Epub 2011 May 7.

PMID:
21571046
19.

Neisseria gonorrhoeae enhances HIV-1 infection of primary resting CD4+ T cells through TLR2 activation.

Ding J, Rapista A, Teleshova N, Mosoyan G, Jarvis GA, Klotman ME, Chang TL.

J Immunol. 2010 Mar 15;184(6):2814-24. doi: 10.4049/jimmunol.0902125. Epub 2010 Feb 10.

20.

Natural phosphoryl and acyl variants of lipid A from Neisseria meningitidis strain 89I differentially induce tumor necrosis factor-alpha in human monocytes.

John CM, Liu M, Jarvis GA.

J Biol Chem. 2009 Aug 7;284(32):21515-25. doi: 10.1074/jbc.M109.004887. Epub 2009 Jun 15.

21.

Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome.

Duncan JA, Gao X, Huang MT, O'Connor BP, Thomas CE, Willingham SB, Bergstralh DT, Jarvis GA, Sparling PF, Ting JP.

J Immunol. 2009 May 15;182(10):6460-9. doi: 10.4049/jimmunol.0802696.

22.

TREM-2 binds to lipooligosaccharides of Neisseria gonorrhoeae and is expressed on reproductive tract epithelial cells.

Quan DN, Cooper MD, Potter JL, Roberts MH, Cheng H, Jarvis GA.

Mucosal Immunol. 2008 May;1(3):229-38. doi: 10.1038/mi.2008.1. Epub 2008 Mar 5.

23.

Profiles of structural heterogeneity in native lipooligosaccharides of Neisseria and cytokine induction.

John CM, Liu M, Jarvis GA.

J Lipid Res. 2009 Mar;50(3):424-38. doi: 10.1194/jlr.M800184-JLR200. Epub 2008 Oct 2.

24.

Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission.

Klotman ME, Rapista A, Teleshova N, Micsenyi A, Jarvis GA, Lu W, Porter E, Chang TL.

J Immunol. 2008 May 1;180(9):6176-85.

25.

Elderly patients have more severe biliary infections: influence of complement-killing and induction of TNFalpha production.

Stewart L, Grifiss JM, Jarvis GA, Way LW.

Surgery. 2008 Jan;143(1):103-12. Epub 2007 Dec 3.

PMID:
18154938
26.
27.

Gallstones containing bacteria are biofilms: bacterial slime production and ability to form pigment solids determines infection severity and bacteremia.

Stewart L, Griffiss JM, Jarvis GA, Way LW.

J Gastrointest Surg. 2007 Aug;11(8):977-83; discussion 983-4.

PMID:
17546479
28.
29.

Biliary bacterial factors determine the path of gallstone formation.

Stewart L, Grifiss JM, Jarvis GA, Way LW.

Am J Surg. 2006 Nov;192(5):598-603.

PMID:
17071191
30.

Gonococcal lipooligosaccharide suppresses HIV infection in human primary macrophages through induction of innate immunity.

Liu X, Mosoian A, Li-Yun Chang T, Zerhouni-Layachi B, Snyder A, Jarvis GA, Klotman ME.

J Infect Dis. 2006 Sep 15;194(6):751-9. Epub 2006 Aug 8.

PMID:
16941340
31.

Binding of the Streptococcus gordonii surface glycoproteins GspB and Hsa to specific carbohydrate structures on platelet membrane glycoprotein Ibalpha.

Takamatsu D, Bensing BA, Cheng H, Jarvis GA, Siboo IR, López JA, Griffiss JM, Sullam PM.

Mol Microbiol. 2005 Oct;58(2):380-92.

32.

Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action.

Scordi-Bello IA, Mosoian A, He C, Chen Y, Cheng Y, Jarvis GA, Keller MJ, Hogarty K, Waller DP, Profy AT, Herold BC, Klotman ME.

Antimicrob Agents Chemother. 2005 Sep;49(9):3607-15.

33.

Human T lymphotropic virus type II infection and humoral responses to pneumococcal polysaccharide and tetanus toxoid vaccines.

Jarvis GA, Janoff EN, Cheng H, Devita D, Fasching C, McCulloch CE, Murphy EL.

J Infect Dis. 2005 Apr 15;191(8):1239-44. Epub 2005 Mar 14.

PMID:
15776369
34.

Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread.

Cheshenko N, Keller MJ, MasCasullo V, Jarvis GA, Cheng H, John M, Li JH, Hogarty K, Anderson RA, Waller DP, Zaneveld LJ, Profy AT, Klotman ME, Herold BC.

Antimicrob Agents Chemother. 2004 Jun;48(6):2025-36.

35.
37.

Truncated galectin-3 inhibits tumor growth and metastasis in orthotopic nude mouse model of human breast cancer.

John CM, Leffler H, Kahl-Knutsson B, Svensson I, Jarvis GA.

Clin Cancer Res. 2003 Jun;9(6):2374-83.

38.

Cholangitis: bacterial virulence factors that facilitate cholangiovenous reflux and tumor necrosis factor-alpha production.

Stewart L, Oesterle AL, Grifiss JM, Jarvis GA, Way LW.

J Gastrointest Surg. 2003 Feb;7(2):191-8; discussion 198-9.

PMID:
12600443
39.

Galectin-3 binds lactosaminylated lipooligosaccharides from Neisseria gonorrhoeae and is selectively expressed by mucosal epithelial cells that are infected.

John CM, Jarvis GA, Swanson KV, Leffler H, Cooper MD, Huflejt ME, Griffiss JM.

Cell Microbiol. 2002 Oct;4(10):649-62.

PMID:
12366402
40.

Gram-negative bacteria killed by complement are associated with more severe biliary infections and produce more tumor necrosis factor-alpha in sera.

Stewart L, Oesterle AL, Griffiss JM, Jarvis GA, Aagaard B, Way LW.

Surgery. 2002 Aug;132(2):408-14.

PMID:
12219042
41.

CEACAM is not necessary for Neisseria gonorrhoeae to adhere to and invade female genital epithelial cells.

Swanson KV, Jarvis GA, Brooks GF, Barham BJ, Cooper MD, Griffiss JM.

Cell Microbiol. 2001 Oct;3(10):681-91.

PMID:
11580753
42.

Mannose-binding lectin accelerates complement activation and increases serum killing of Neisseria meningitidis serogroup C.

Jack DL, Jarvis GA, Booth CL, Turner MW, Klein NJ.

J Infect Dis. 2001 Oct 1;184(7):836-45. Epub 2001 Aug 15.

PMID:
11509995
43.
45.
46.
47.

Expression and function of the complement membrane attack complex inhibitor protectin (CD59) in human prostate cancer.

Jarvis GA, Li J, Hakulinen J, Brady KA, Nordling S, Dahiya R, Meri S.

Int J Cancer. 1997 Jun 11;71(6):1049-55.

48.

Bacterial enzymes can add galactose alpha 1,3 to human erythrocytes and creates a senescence-associated epitope.

Hamadeh RM, Jarvis GA, Zhou P, Cotleur AC, Griffiss JM.

Infect Immun. 1996 Feb;64(2):528-34.

49.

Anti-Gal binds to pili of Neisseria meningitidis: the immunoglobulin A isotype blocks complement-mediated killing.

Hamadeh RM, Estabrook MM, Zhou P, Jarvis GA, Griffiss JM.

Infect Immun. 1995 Dec;63(12):4900-6.

50.

Recognition and control of neisserial infection by antibody and complement.

Jarvis GA.

Trends Microbiol. 1995 May;3(5):198-201. Review.

PMID:
7627458

Supplemental Content

Loading ...
Support Center